Save, make, understand money

Experienced Investor

Woodford tops most traded funds in February – The Share Centre

Paloma Kubiak
Written By:
Paloma Kubiak

Star fund manager Neil Woodford has topped the table of the most traded funds for the ninth consecutive month according to The Share Centre’s customer data.

The CF Woodford Equity Income fund continues to be hugely popular among The Share Centre’s investors as it ranks first place in a list of the 10 traded funds based on the number of deals completed in February.

Two new funds entered the top 10 list last month, while the HSBC FTSE 250 Index fund and the Polar Capital Healthcare Opportunities fund, were demoted from the latest top traded deals.

Here are the top 10:

1. CF Woodford Equity Income
2. Fundsmith Equity
3. Blackrock Gold & General
4. CF Miton UK Value Opportunities
5. Axa Framlington Biotech
6. Legg Mason Japan Equity
7. Marlborough Special Situations
8. Old Mutual UK Mid-Cap
9. L&G UK Index
10. CF Lindsell Train UK Equity

Andy Parsons, head of investment research, said investors continue to want to benefit from the expertise and knowledge of one of the industry’s most highly respected fund managers in the CF Woodford Equity Income fund. The fund offers a portfolio which comprises a core of blue chip companies and a number of exciting young businesses just starting out.

The Fundsmith Equity fund invests in equities on a global basis and is managed by the highly acclaimed founder of the business, Terry Smith.  Investing in typically between 20-30 names “clearly demonstrates the manager’s conviction in the highly concentrated portfolio of global names in which he invests,” said Parsons.

In turbulent times when markets are gripped with fear and uncertainty, investors often seek the safe haven of gold as a protection. As a result, the Blackrock Gold & General fund comes in third place, returning to the top 10 after quite some time.

The CF Miton UK Value Opportunities fund is managed by George Godber and Georgina Hamilton and aims to identify UK companies trading at a significant discount through a robust, bottom-up stock selection policy.

Midway through the table is the Axa Framlington Biotech fund. The biotech sector came under real pressure in January during the market sell off, losing about 20%. Parsons said that as an investment theme and long term story, he still believes “this is an exciting sector” to have exposure to though investors need to be aware of the risks and volatility that it can bring to a portfolio.

In sixth and seventh positions this month are the Legg Mason Japan Equity and the Marlborough Special Situations funds, respectively. The Legg Mason Japan Equity fund aims to play the internal consumer based around three key themes of rapid emergence of the internet as a sales channel, ageing population and the medical and long-term care industries, Parsons added. The Marlborough Special Situations fund, managed by Giles Hargreave, combines a variety of investment approaches, investing in smaller companies, new issuants and seeking companies that are going through difficult times but have good recovery prospects.

The Old Mutual UK Mid-Cap fund retains a presence within the top 10 as it “seeks to provide capital growth from investing primarily in a portfolio of medium sized UK companies, serving as an ideal investment opportunity for those seeking true mid-cap exposure”.

Index tracker fund L&G UK Index, which seeks to replicate the performance of the FTSE All-Share index, has reappeared in ninth place.

And trailing in last place is the CF Lindsell Train UK Equity fund which aims to achieve capital and income growth and provide a total return in excess of that of the FTSE All-Share.